128 related articles for article (PubMed ID: 17430490)
1. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
[TBL] [Abstract][Full Text] [Related]
2. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy.
Pappas PA; Weppler D; Pinna AD; Rusconi P; Thompson JF; Jaffe JS; Tzakis AG
Pediatr Transplant; 2000 Feb; 4(1):45-9. PubMed ID: 10731058
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
[TBL] [Abstract][Full Text] [Related]
5. Dilated Cardiomyopathy in an Adult Renal Transplant Recipient: Recovery Upon Tacrolimus to Sirolimus Switch: A Case Report.
Kakhi S; Phanish MK; Anderson L
Transplant Proc; 2020 Nov; 52(9):2758-2761. PubMed ID: 32703671
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.
Chang RK; McDiarmid SV; Alejos JC; Drant SE; Klitzner TS
Pediatr Transplant; 2001 Jun; 5(3):187-91. PubMed ID: 11422821
[TBL] [Abstract][Full Text] [Related]
7. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
Baruch Y; Weitzman E; Markiewicz W; Eisenman A; Eid A; Enat R
Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
[No Abstract] [Full Text] [Related]
8. Lack of tacrolimus-induced cardiomyopathy.
Coley KC; Verrico MM; McNamara DM; Park SC; Cressman MD; Branch RA
Ann Pharmacother; 2001 Sep; 35(9):985-9. PubMed ID: 11573873
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
Toth CC; Burak K; Becker W
Headache; 2005 Mar; 45(3):245-6. PubMed ID: 15836601
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
13. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.
Acquazzino MA; Fischer RT; Langnas A; Coulter DW
Pediatr Transplant; 2013 Aug; 17(5):466-71. PubMed ID: 23730873
[TBL] [Abstract][Full Text] [Related]
14. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
Forgacs B; Merhav HJ; Lappin J; Mieles L
Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502
[TBL] [Abstract][Full Text] [Related]
15. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
[TBL] [Abstract][Full Text] [Related]
16. Recovery of tacrolimus-associated brachial neuritis after conversion to everolimus in a pediatric renal transplant recipient--case report and review of the literature.
Al Masri O; Fathallah W; Quader S
Pediatr Transplant; 2008 Dec; 12(8):914-7. PubMed ID: 18503483
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?
Scott JS; Boyle GJ; Daubeney PE; Miller SA; Law Y; Pigula F; Griffith BP; Webber SA
Transplant Proc; 1999; 31(1-2):82-3. PubMed ID: 10083017
[No Abstract] [Full Text] [Related]
18. Replacing calcineurin inhibitors with mTOR inhibitors in children.
Sindhi R; Seward J; Mazariegos G; Soltys K; Seward L; Smith A; Kosmach B; Venkataramanan R
Pediatr Transplant; 2005 Jun; 9(3):391-7. PubMed ID: 15910398
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
20. [Hypertrophic cardiomyopathy in preterm newborn with kidney transplanted mother].
Méndez-Abad P; Zafra-Rodríguez P
Arch Argent Pediatr; 2018 Dec; 116(6):e749-e752. PubMed ID: 30457729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
